IC
IRON icon

Ikarian Capital’s Disc Medicine IRON Stock Holding History

Ikarian Capital’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-396,600
Closed -$24.7M – 140
2024
Q1 		$24.7M Buy
+396,600
New +$25.7M 2.71% 6
2023
Q4 		– Sell
-1,526
Closed -$7.17M – 156
2023
Q3 		$7.17M Buy
+1,526
New +$76.3K 0.86% 34

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital's IRON Position: Q2 2024 in Review

Ikarian Capital sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 25,372 shares — an estimated $1.58M sold.

Ikarian Capital first reported a position in IRON in Q1 2021 and held it in 10 quarters. The position peaked at $11.3M in Q4 2023. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Ikarian Capital reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Ikarian Capital sold 25,372 Disc Medicine shares in Q2 2024, an estimated $1.58M.
  • Ikarian Capital first reported a position in Disc Medicine in Q1 2021 and held it in 10 quarters.
  • Ikarian Capital's Disc Medicine position peaked at $11.3M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Ikarian Capital's 13F filing for Q2 2024, filed 14 Aug 2024.